Skip to content

Paragon Diagnostics, Inc.

United StatesFDA applicant, unverified

Devices
7

What Paragon Diagnostics, Inc. makes

Paragon Diagnostics, Inc. manufactures in vitro diagnostic reagents and systems for measuring drug concentrations in patient samples. Their products include assay reagents for theophylline, gentamicin, T4 thyroid hormone, tobramycin, amikacin, and tuberculosis (TBC), alongside the IMMPULSE system for automated testing.

These devices are regulated under FDA 510(k) clearance, with classifications spanning Class I and Class II. The company’s products are listed in the FDA’s 510(k) registry and are based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue7

Newest first, rows 1-7 of 7

Frequently asked questions

How many devices does Paragon Diagnostics, Inc. have in the registry?

The registry currently lists 7 devices for Paragon Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Paragon Diagnostics, Inc.'s devices?

Among its 7 most recently registered devices, Paragon Diagnostics, Inc. has devices listed in FDA 510(k) (7 devices).

What risk classes do Paragon Diagnostics, Inc.'s devices fall under?

Among its 7 most recently registered devices, the classes recorded for Paragon Diagnostics, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

What are the newest devices from Paragon Diagnostics, Inc. in the registry?

The most recently registered devices listed for Paragon Diagnostics, Inc. include IMMPULSE THEOPHYLLINE ASSAY REAGENTS, IMMPULSE SYSTEM, IMMPULSE GENTAMICIN ASSAY REAGENTS and IMMPULSE T4 ASSAY REAGENTS.

Generated automatically from registry data and not verified by a human reviewer.